CDH13 and cancer: Downregulation of CDH13 is frequently observed in many types of cancer, including ovarian carcinoma 6, gastric cancer 7, colorectal cancer 8, bladder transitional cell carcinoma 9, breast cancer 10 and gallbladder cancer11, and is generally associated with poor prognosis 12.